熵基科技(301330) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥399,677,922.33, a decrease of 0.83% compared to ¥403,022,827.48 in the same period last year[4] - Net profit attributable to shareholders was ¥26,334,496.73, down 16.90% from ¥31,690,542.22 year-on-year[4] - The net profit excluding non-recurring gains and losses was ¥21,211,610.69, reflecting a decline of 29.95% from ¥30,281,180.21 in the previous year[4] - Basic earnings per share decreased by 35.03% to ¥0.1363 from ¥0.2098 in the same quarter last year[4] - Total operating revenue for Q1 2024 was CNY 399,677,922.33, a decrease of 0.86% from CNY 403,022,827.48 in Q1 2023[19] - Net profit for Q1 2024 was CNY 27,332,851.76, down 27.2% compared to CNY 37,516,773.30 in Q1 2023[19] - The total comprehensive income for Q1 2024 is ¥23,827,807.59, down from ¥32,737,067.74 in the same period last year, reflecting a decline of 27.2%[20] - The basic earnings per share for Q1 2024 is ¥0.1363, compared to ¥0.2098 in Q1 2023, representing a decrease of 34.9%[20] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥3,842,695,159.18, down 2.07% from ¥3,923,900,732.70 at the end of the previous year[4] - Total liabilities decreased to CNY 582,625,104.69 from CNY 633,111,389.42, a decline of 7.97%[16] - The company’s total equity decreased to CNY 3,260,070,054.49 from CNY 3,290,789,343.28, a decline of 0.93%[16] - The company reported a decrease in accounts receivable to CNY 446,451,642.30 from CNY 479,803,313.66, a drop of 6.94%[16] - Inventory increased to CNY 384,035,852.46, up 3.54% from CNY 372,714,784.31[16] Cash Flow - The cash flow from operating activities was ¥61,516,123.25, a decrease of 4.43% compared to ¥64,369,898.55 in the previous year[4] - Cash inflows from operating activities for Q1 2024 amount to ¥578,355,451.35, an increase of 18.1% from ¥489,775,245.32 in Q1 2023[22] - The net cash flow from operating activities for Q1 2024 is ¥61,516,123.25, a decrease of 4.3% compared to ¥64,369,898.55 in Q1 2023[22] - The net cash flow from investing activities for Q1 2024 is -¥51,857,022.79, a significant decline from ¥8,704,305.63 in Q1 2023[22] - The net cash flow from financing activities for Q1 2024 is -¥69,620,223.57, worsening from -¥20,327,769.95 in the previous year[22] - The ending cash and cash equivalents balance for Q1 2024 is ¥1,258,116,460.63, down from ¥1,126,682,034.58 in Q1 2023, indicating a decrease of 8.9%[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,470[10] - The company reported a total of 9,880,000 shares held by Dongguan Lixin Investment, accounting for 5.08% of total shares[11] - Shenzhen Elite Lixin Consulting holds 4,717,910 shares, representing 2.42% of total shares[11] - As of March 31, 2024, the company has a total of 2,230,000 shares in its repurchase account, which is 1.15% of the total share capital[12] - The top ten shareholders include Shenzhen Elite Shijun Investment with 3,526,900 shares and Shenzhen Elite Heyi Investment with 3,480,263 shares[11] Strategic Initiatives - The company plans to adjust the investment method and total amount for the "R&D Center Construction Project," utilizing existing idle space instead of new construction[13] - The company has postponed the expected completion dates for the "Mixed Biological Recognition IoT Intelligent Industry Base Project" and the "R&D Center Construction Project"[13] - The company reported a significant increase in user data, with a focus on expanding its market presence[12] - The company is actively engaged in new product and technology development initiatives to enhance its competitive edge[12] - The financial report indicates a strong commitment to strategic investments and market expansion efforts[12] - The company is exploring potential mergers and acquisitions to further strengthen its market position[12] Taxation - The company experienced a 104.36% increase in taxes and surcharges, primarily due to tax calculations by overseas subsidiaries[8] - The company received tax refunds of ¥21,527,469.95 in Q1 2024, slightly up from ¥21,026,770.27 in Q1 2023[22] Research and Development - Research and development expenses rose to CNY 51,910,740.47, an increase of 9.4% from CNY 47,376,880.92 in the same period last year[19] - The company reported a significant increase in other non-current assets by 37.16% due to payments for the implementation of a new ERP system[8]